Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

January 29, 2013; 80 (5) Editorial

Making sense of genetic heterogeneity

Emergence of pathways in developmental brain disorders

Alex R. Paciorkowski, Basil T. Darras
First published January 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31827f101c
Alex R. Paciorkowski
From the Departments of Neurology, Pediatrics, and Biomedical Genetics (A.R.P.), Center for Neural Development & Disease, University of Rochester Medical Center, Rochester, NY; and Department of Neurology (B.T.D.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Basil T. Darras
From the Departments of Neurology, Pediatrics, and Biomedical Genetics (A.R.P.), Center for Neural Development & Disease, University of Rochester Medical Center, Rochester, NY; and Department of Neurology (B.T.D.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Making sense of genetic heterogeneity
Emergence of pathways in developmental brain disorders
Alex R. Paciorkowski, Basil T. Darras
Neurology Jan 2013, 80 (5) 426-427; DOI: 10.1212/WNL.0b013e31827f101c

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
168

Share

  • Article
  • Info & Disclosures
Loading

Article Information

vol. 80 no. 5 426-427
DOI: 
https://doi.org/10.1212/WNL.0b013e31827f101c
PubMed: 
23284070

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 2, 2013.

Article Versions

  • Previous version (January 2, 2013 - 12:56).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Alex R. Paciorkowski, MD and
    2. Basil T. Darras, MD
  1. Alex R. Paciorkowski, MD and
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Basil T. Darras, MD
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. (1) Athena Diagnostics, Honorarium for Virtual Grand, Rounds (SMA) - 2010

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. (1) Various titles, UpToDate, 1999-present

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) ISIS Pharmaceuticals, (2) Quest Diagnostics, (3) Guidepoint Global Consultation, (4) Easton Associates Consultation, (5) Gershon Lehrman Group

    Speakers' Bureaus:
    1. (1) Athena Diagnostics

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) PTC Therapeutics, (2) Isis Pharmaceuticals

    Research Support, Government Entities:
    1. (1) NIH/NIAMS, 2P01 NS040828-6A11, co-PI, 2000-2012. (2) NIH/NINDS, 1U10NS077269, co-PI/PD, 2011-2018. (3) NIH/NIAMS, 1R01AR060850, co-PI, 2011-2015.

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) SMA Foundation, (2) Muscular Dystrophy Association, (3) Slaney Family Fund for SMA

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Departments of Neurology, Pediatrics, and Biomedical Genetics (A.R.P.), Center for Neural Development & Disease, University of Rochester Medical Center, Rochester, NY; and Department of Neurology (B.T.D.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
  1. Correspondence to Dr. Paciorkowski: alex_paciorkowski{at}urmc.rochester.edu
View Full Text

Article usage

Article usage: January 2013 to April 2022

AbstractFullPdfSource
Jan 201301571Highwire
Feb 201301520Highwire
Mar 2013086Highwire
Apr 2013058Highwire
May 2013022Highwire
Jun 20131532Highwire
Jul 20131144Highwire
Aug 2013810Highwire
Sep 20131703Highwire
Oct 20131301Highwire
Nov 2013343Highwire
Dec 2013825Highwire
Jan 2014311Highwire
Feb 2014622Highwire
Mar 2014721Highwire
Apr 20141154Highwire
May 2014300Highwire
Jun 20141422Highwire
Jul 20141321Highwire
Aug 2014721Highwire
Sep 2014510Highwire
Oct 20141510Highwire
Nov 2014200Highwire
Dec 2014700Highwire
Jan 2015641Highwire
Feb 2015811Highwire
Mar 20151211Highwire
Apr 2015700Highwire
May 2015711Highwire
Jun 20151612Highwire
Jul 20151600Highwire
Aug 20151331Highwire
Sep 20151200Highwire
Oct 2015911Highwire
Nov 2015600Highwire
Dec 20151410Highwire
Jan 2016900Highwire
Feb 2016811Highwire
Mar 2016400Highwire
Apr 2016400Highwire
May 2016222Highwire
Jun 2016800Highwire
Jul 20163000Highwire
Aug 20161700Highwire
Sep 2016800Highwire
Oct 20161702Highwire
Nov 20161000Highwire
Dec 2016900Highwire
Jan 20171810Highwire
Feb 2017511Highwire
Mar 2017500Highwire
Apr 2017600Highwire
May 20171000Highwire
Jun 2017900Highwire
Jul 2017100Highwire
Aug 2017711Highwire
Sep 2017601Highwire
Oct 2017611Highwire
Nov 2017300Highwire
Dec 20171700Highwire
Jan 2018900Highwire
Feb 20181700Highwire
Mar 20182601Highwire
Apr 20182111Highwire
May 20182000Highwire
Jun 2018800Highwire
Jul 20181310Highwire
Aug 2018301Highwire
Sep 20181201Highwire
Oct 2018501Highwire
Nov 2018810Highwire
Dec 2018500Highwire
Jan 2019502Highwire
Feb 2019400Highwire
Mar 2019700Highwire
Apr 2019200Highwire
May 2019820Highwire
Jun 2019700Highwire
Jul 2019531Highwire
Aug 2019101Highwire
Sep 2019100Highwire
Oct 20191100Highwire
Nov 2019800Highwire
Dec 2019401Highwire
Jan 2020400Highwire
Feb 2020500Highwire
Mar 2020100Highwire
Apr 2020600Highwire
May 2020800Highwire
Jun 2020300Highwire
Jul 2020511Highwire
Aug 2020700Highwire
Sep 2020500Highwire
Oct 20201000Highwire
Nov 20201910Highwire
Dec 20201200Highwire
Jan 2021300Highwire
Feb 20211012Highwire
Mar 20211100Highwire
Apr 20211200Highwire
May 2021800Highwire
Jun 2021200Highwire
Jul 20211600Highwire
Aug 20211100Highwire
Sep 2021600Highwire
Oct 20211600Highwire
Nov 20211910Highwire
Dec 2021600Highwire
Jan 2022400Highwire
Feb 20221801Highwire
Mar 20221400Highwire
Apr 20221900Highwire

Cited By...

  • 3 Citations
  • Google Scholar

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • STUDY FUNDING
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Disclosures
Advertisement

Related Articles

  • Pontocerebellar hypoplasia type 1Clinical spectrum and relevance of EXOSC3 mutations
  • Warfarin treatment and thrombolysisHow to persuade procrastinators?
  • tPA and warfarinTime to move forward
  • Neighborhood socioeconomic status and stroke mortalityDisentangling individual and area effects
  • The border-land of epilepsy—Revisited
  • Diagnostic shifts in ALS?From clinical specter to imaging spectra
  • Biomarkers for PDHow can we approach complexity?
  • Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS
  • Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease

Topics Discussed

  • All Genetics
  • Developmental disorders

Alert Me

  • Alert me when eletters are published

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise